Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: We are but a few

The reason for including the broker non-votes is fairly simple: it exemplifies shareholder apathy - add the totals then subtract from shares o/s.

As to addressing majority voting, how soon do you expect the next ASM?

Returning to those shareholders who failed to vote, isn't the Company able to canvass shareholders for their votes? Please don't assume that majority voting will be the panacea to removal of the current BoD, but you'd know this anyway, wouldn't you?

What was the market cap on November 30 2010?

.

.

.

Be well

Share
New Message
Please login to post a reply